Dr Neha Jain

Inflection Point Ventures was started in 2018 with the aim of driving exponential value creation by being India’s most accessible & efficient network connecting a diverse investor community with a carefully set of curated startups. IPV is an early-stage angel investing platform, which provides both monetary and non-monetary support to the startups, as well as complete transparency around valuation, findings during due diligence, and personal interest (if any) to its investors. Today, it has 14,000+ angel investors, with the community having expanded beyond CXOs to include HNIs who come from varied backgrounds, professions and areas of expertise. IPV caters to investors pan India, and overseas, giving them access to startups and deals, making the group location and region agnostic. Since inception, we have invested in 250+ startups, with more in advanced stages of negotiations. IPV evaluation process screens startups and presents to investors only those, we feel have the potential to scale up. Till date we have considered startups spanning various industries such as Healthcare, Sports and Fitness, Retail Finance, HR, AI in hiring, Education, Supply Chain and Logistics etc, which shows that we do not have any predefined restrictions. For more information please visit our website.

Inflection Point Ventures was started in 2018 with the aim of driving exponential value creation by being India’s most accessible & efficient network connecting a diverse investor community with a carefully set of curated startups. IPV is an early-stage angel investing platform, which provides both monetary and non-monetary support to the startups, as well as complete transparency around valuation, findings during due diligence, and personal interest (if any) to its investors. Today, it has 14,000+ angel investors, with the community having expanded beyond CXOs to include HNIs who come from varied backgrounds, professions and areas of expertise. IPV caters to investors pan India, and overseas, giving them access to startups and deals, making the group location and region agnostic. Since inception, we have invested in 250+ startups, with more in advanced stages of negotiations. IPV evaluation process screens startups and presents to investors only those, we feel have the potential to scale up. Till date we have considered startups spanning various industries such as Healthcare, Sports and Fitness, Retail Finance, HR, AI in hiring, Education, Supply Chain and Logistics etc, which shows that we do not have any predefined restrictions. For more information please visit our website.

About the Agency for Science, Technology and Research (A*STAR) The Agency for Science, Technology and Research (A*STAR) is Singapores lead public sector agency that spearheads economic oriented research to advance scientific discovery and develop innovative technology. Through open innovation, we collaborate with our partners in both the public and private sectors to benefit society. As a Science and Technology Organisation, A*STAR bridges the gap between academia and industry. Our research creates economic growth and jobs for Singapore, and enhances lives by contributing to societal benefits such as improving outcomes in healthcare, urban living, and sustainability. We play a key role in nurturing and developing a diversity of talent and leaders in our Agency and research entities, the wider research community and industry. A*STAR’s R&D activities span biomedical sciences and physical sciences and engineering, with research entities primarily located in Biopolis and Fusionopolis. For ongoing news, visit www.a-star.edu.sg.